A memo from Jack Wood stated that for inventory which could not be reallocated by Cutter US they were to seek a one year extension from NIBS to allow them to relabel and sell over the coming year into markets not yet converted to heat-treated Factor 8 products.

Chronology Information

Date:

Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Jack Wood